CASO, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 7.319
NA - Nord America 5.095
EU - Europa 3.971
SA - Sud America 790
AF - Africa 142
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.336
Nazione #
US - Stati Uniti d'America 4.849
SG - Singapore 3.369
RU - Federazione Russa 1.953
CN - Cina 1.384
VN - Vietnam 1.193
IT - Italia 718
BR - Brasile 630
HK - Hong Kong 626
FR - Francia 328
DE - Germania 209
JP - Giappone 169
IE - Irlanda 153
NL - Olanda 151
CA - Canada 137
BD - Bangladesh 122
IN - India 117
FI - Finlandia 111
GB - Regno Unito 91
KR - Corea 77
MX - Messico 59
AR - Argentina 50
SE - Svezia 49
IQ - Iraq 42
ES - Italia 35
UA - Ucraina 33
ZA - Sudafrica 33
PH - Filippine 31
PL - Polonia 29
EC - Ecuador 27
CI - Costa d'Avorio 25
CO - Colombia 23
ID - Indonesia 21
TH - Thailandia 21
TR - Turchia 21
VE - Venezuela 20
TW - Taiwan 19
AT - Austria 18
MA - Marocco 18
CH - Svizzera 16
PY - Paraguay 16
PK - Pakistan 15
SA - Arabia Saudita 14
CL - Cile 13
UZ - Uzbekistan 13
AU - Australia 12
TN - Tunisia 11
EG - Egitto 9
JO - Giordania 9
LB - Libano 9
LT - Lituania 9
BE - Belgio 8
JM - Giamaica 8
RO - Romania 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
CR - Costa Rica 6
DZ - Algeria 6
KE - Kenya 6
AZ - Azerbaigian 5
BG - Bulgaria 5
ET - Etiopia 5
NP - Nepal 5
PE - Perù 5
TT - Trinidad e Tobago 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
GA - Gabon 4
GR - Grecia 4
GT - Guatemala 4
HR - Croazia 4
HU - Ungheria 4
IL - Israele 4
LU - Lussemburgo 4
PA - Panama 4
SN - Senegal 4
SV - El Salvador 4
UY - Uruguay 4
MN - Mongolia 3
MY - Malesia 3
NI - Nicaragua 3
PR - Porto Rico 3
RS - Serbia 3
SY - Repubblica araba siriana 3
BS - Bahamas 2
BZ - Belize 2
CG - Congo 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EU - Europa 2
GF - Guiana Francese 2
GN - Guinea 2
GP - Guadalupe 2
HN - Honduras 2
KW - Kuwait 2
LV - Lettonia 2
MR - Mauritania 2
MW - Malawi 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
Totale 17.299
Città #
Singapore 1.614
San Jose 828
Hong Kong 602
Moscow 532
Ashburn 467
Ho Chi Minh City 379
Hefei 356
Santa Clara 301
Beijing 283
Chandler 269
Hanoi 267
The Dalles 216
Naples 187
Lauterbourg 181
Millbury 179
Tokyo 156
Los Angeles 135
Des Moines 119
Amsterdam 115
Princeton 101
Boston 100
Nanjing 90
Redondo Beach 85
Buffalo 81
New York 74
Napoli 71
Lawrence 63
Seoul 63
Dallas 55
Munich 53
Ottawa 53
Da Nang 49
Wilmington 43
Frankfurt am Main 42
Milan 42
São Paulo 42
Rome 39
Orem 34
Haiphong 33
Nanchang 32
Mexico City 31
Turku 29
Seattle 28
Cava de' Tirreni 27
Chicago 26
Dublin 26
Helsinki 25
Brooklyn 24
Montreal 24
Toronto 23
Hải Dương 22
Nuremberg 22
Council Bluffs 21
Chennai 20
Falkenstein 20
Hangzhou 20
Warsaw 20
Johannesburg 19
Baghdad 18
Denver 18
Belo Horizonte 17
Biên Hòa 17
Atlanta 16
New Delhi 16
Shanghai 16
Tianjin 16
Shenyang 15
Washington 15
Jacksonville 14
London 14
Phoenix 14
San Francisco 14
Hebei 13
Mumbai 13
Phủ Lý 13
Poplar 13
Redwood City 13
Woodbridge 13
Brasília 12
Dong Ket 12
Fairfield 12
Houston 12
Jiaxing 12
Thái Nguyên 12
Zurich 12
Ankara 11
Bến Tre 11
Can Tho 11
Düsseldorf 11
Guangzhou 11
Porto Alegre 11
Ribeirão Preto 11
Boardman 10
Curitiba 10
Fuzhou 10
Guayaquil 10
Hyderabad 10
Manchester 10
Rio de Janeiro 10
Tashkent 10
Totale 9.397
Nome #
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease 198
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 163
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 160
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 148
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 145
Fragility Fractures in Patients with Psoriatic Arthritis 143
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 139
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 138
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 138
IL-17-induced inflammation modulates the mPGES-1/PPAR-gamma pathway in monocytes/macrophages 136
Psoriatic arthritis and psoriasis: differential diagnosis 135
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 132
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment 131
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 126
Small molecule therapy for managing moderate to severe psoriatic arthritis 124
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 123
Dactylitis in enteropathic spondyloarthritis 122
Magnetic resonance imaging of nail unit in psoriatic arthritis 122
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept 120
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 120
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 119
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 118
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 118
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 118
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 118
Exploring the dual role of Mangifera indica L. in regulating immune response and pain persistence in inflammatory bowel disease 117
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome 117
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 117
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 117
IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation 117
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 116
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 116
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease 115
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms 115
Serum amyloid-A in Beh?et's disease. 115
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 115
Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization 114
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 114
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? 112
Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment 112
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al 111
JAK/STAT/PKC? molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis 110
Simple clinical indicators for early psoriatic arthritis detection 110
JAK Inhibitors in Psoriatic Disease 109
Prevention of rheumatoid arthritis using a familial predictive medicine approach 109
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 109
Refractory pemphigus foliaceus and Beh?et?s disease successfully treated with tocilizumab 109
Treatment options: NSAIDs and DMARDs 109
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 109
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 109
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 108
Biological treatments in Behçet's disease: beyond anti-TNF therapy 108
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 108
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. 105
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. 103
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 102
Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis 102
The definition and measurement of axial psoriatic arthritis 102
New developments in magnetic resonance imaging of the nail unit. 101
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis 101
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 101
The enthesopathy of celiac patients: Effects of gluten-free diet 101
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 100
Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond 100
Decrease of serum C-reactive protein levels in psoriatic arthritis patients treated with TNF alpha blockers 100
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules". 100
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 99
Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs 98
The enthesopathy of celiac patients: effects of gluten-free diet 98
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 97
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 96
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 96
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 95
Anakinra treatment in drug-resistant Behcet’s disease: a case series 95
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints 94
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 94
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach 93
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. 93
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 93
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study 92
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 92
The role of bDMARDs in the prevention and treatment of inflammatory-related comorbidities in Psoriatic Arthritis 91
The use of TNF-? blockers in psoriatic arthritis patients with latent tuberculosis infection. 91
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments 90
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study 90
Blau syndrome and latent tubercular infection: an unresolved partnership 89
Diagnosis and classification of relapsing polychondritis 88
Ex vivo signaling protein mapping in T lymphocytes in the psoriatic arthritis joints 87
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 87
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 87
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease 86
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 86
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 85
Emerging drugs for psoriatic arthritis 85
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 85
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 84
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 84
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain 84
Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients 83
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 83
Totale 10.889
Categoria #
all - tutte 57.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 0 0 0 0 0 0 17
2021/2022771 8 6 1 0 2 33 3 34 140 32 125 387
2022/2023819 165 24 26 42 96 80 6 90 104 109 65 12
2023/2024740 32 106 120 48 33 86 16 52 13 10 142 82
2024/20255.024 404 368 25 77 88 306 503 311 439 506 1.542 455
2025/20269.243 1.093 856 957 848 1.392 393 955 790 1.172 470 312 5
Totale 17.659